Danel (Adir Yeoshua) Ltd (TLV:DANE)
Israel
· Delayed Price · Currency is ILS · Price in ILA 46,890
+230 (0.49%)
Apr 29, 2026, 5:11 PM IDT
Danel (Adir Yeoshua) Revenue
In the year 2025, Danel (Adir Yeoshua) had annual revenue of 2.90B ILS with 5.26% growth.
Revenue
2.90B
Revenue Growth
+5.26%
P/S Ratio
0.96
Revenue / Employee
677.34K
Employees
4,288
Market Cap
2.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.90B | 145.18M | 5.26% |
| Dec 31, 2024 | 2.76B | 259.93M | 10.40% |
| Dec 31, 2023 | 2.50B | 135.37M | 5.73% |
| Dec 31, 2022 | 2.36B | 75.20M | 3.29% |
| Dec 31, 2021 | 2.29B | 303.89M | 15.31% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.02B |
| Amal Holdings A.D. | 2.18B |
| BrainsWay | 166.49M |
| SofWave Medical | 279.39M |
| Kamada | 575.31M |
| Bait Bakfar | 109.62M |
| Ilex Medical | 930.83M |
| Novolog (Pharm-Up 1966) | 1.81B |